Opnurasib, CAS [[2653994-08-0]]
Artikelnummer:
MCE-HY-139612
| Artikelname: |
Opnurasib, CAS [[2653994-08-0]] |
| Artikelnummer: |
MCE-HY-139612 |
| Hersteller Artikelnummer: |
HY-139612 |
| Alternativnummer: |
MCE-HY-139612-50MG,MCE-HY-139612-1MG,MCE-HY-139612-10MG,MCE-HY-139612-5MG,MCE-HY-139612-25MG,MCE-HY-139612-10MMX1ML |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Biochemikalien |
| Alternative Synonym: |
JDQ-443, NVP-JDQ443 |
| Opnurasib (JDQ-443) (NVP-JDQ443) is an orally active, potent, selective, and covalent KRAS G12C inhibitor (extracted from patent WO2021120890A1). Opnurasib shows antitumor activity[1][2]. |
| Molekulargewicht: |
526.03 |
| Reinheit: |
98.94 |
| CAS Nummer: |
[2653994-08-0] |
| Formel: |
C29H28ClN7O |
| Target-Kategorie: |
PERK,Ras |
| Anwendungsbeschreibung: |
Reference compound |
